According to Sonoma Pharmaceuticals's latest financial reports the company has $2.4 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-03-31 | $3.82 M | -48.35% |
2022-03-31 | $7.39 M | 75.26% |
2021-03-31 | $4.22 M | 14.33% |
2020-03-31 | $3.69 M | 0.05% |
2019-03-31 | $3.68 M | -63.35% |
2018-03-31 | $10.06 M | -42.35% |
2017-03-31 | $17.46 M | 133.78% |
2016-03-31 | $7.46 M | 21.72% |
2015-03-31 | $6.13 M | 11.97% |
2014-03-31 | $5.48 M | -30.63% |
2013-03-31 | $7.9 M | 135.75% |
2012-03-31 | $3.35 M | -23.34% |
2011-03-31 | $4.37 M | -30.15% |
2010-03-31 | $6.25 M | 225.77% |
2009-03-31 | $1.92 M | -89.79% |
2008-03-31 | $18.82 M | -1.19% |
2007-03-31 | $19.05 M | 155.77% |
2006-03-31 | $7.44 M | 126.59% |
2005-03-31 | $3.28 M | |
2003-03-31 | $0.17 M | -76.83% |
2002-03-31 | $0.76 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | 3,885.08% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $20.82 M | 765.38% | ๐บ๐ธ USA |